Investors

Invest in the future of pain relief

Pain is universal. It disrupts work, time with family, and quality of life. Through innovations, we can make a difference.

Virpax® Pharmaceuticals is collaborating with the best minds of the pharmaceutical industry. Working alongside these leaders, we can improve pain management and target pain at its source.

Partner with us as we develop the next generation of pharmaceutical products that can minimize pain and improve people's lives.

Become a partner

  484-875-3195

  info@virpaxpharma.com

Product Pipeline

Virpax® in the news

Press release - February 5, 2020

Virpax® Pharmaceuticals Selected for Two Presentations at the 2020 Special Operations Medical Association Exhibition

Abstracts featuring DSF100 and NES100 will be presented at this year's exhibition.

Read more...

Press release - January 14, 2020

Virpax® to Develop Its Molecular Envelope Technology (MET) Intranasal Enkephalin Formulation for the Management of PTSD

Virpax has exclusive global rights to use Nanomerics’ nanotechnology for the delivery of a metabolically labile intranasal peptide for the management of Post-Traumatic Stress Disorder (PTSD).

Read more...

Press release - October 22, 2019

Michèle C. Linde Promoted to EVP, Global Corporate Governance, Chief Legal Officer & Corporate Secretary for Virpax® Pharmaceuticals

Michèle C. Linde has been promoted to EVP, Global Corporate Governance, Chief Legal Officer & Corporate Secretary.

Read more...

more Articles

Corporate headquarters

101 Lindenwood Drive, Suite 225

Malvern, PA 19355

Phone   484-875-3195

Email     info@virpaxpharma.com

© Virpax® Pharmaceuticals. All Rights Reserved.